🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

80+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 80 recruiting trials for “idiopathic-pleuroparenchymal-fibroelastosis

Phase 2RecruitingNCT05975983

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

🏥 InSilico Medicine Hong Kong Limited📍 12 sites📅 Started Feb 2024View details ↗
NARecruitingNCT06251687

Application of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary Fibrosis

🏥 China-Japan Friendship Hospital📍 1 site📅 Started Feb 2024View details ↗
Phase 1RecruitingNCT06230822

Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF)

🏥 Wuhan Optics Valley Vcanbiopharma Co., Ltd.📍 4 sites📅 Started Feb 2024View details ↗
Phase 2RecruitingNCT05571059

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

👨‍⚕️ Todd Rice, MD, MSc, Cumberland Pharmaceuticals📍 19 sites📅 Started Jan 2024View details ↗
EARLY_Phase 1RecruitingNCT06267183

A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.

🏥 Shanghai Synvida Biotechnology Co.,Ltd.📍 1 site📅 Started Jan 2024View details ↗
NARecruitingNCT05989698

Validation of the C-mo System - Cough Monitoring

👨‍⚕️ Nuno M Neuparth, PhD, NOVA Medical School | Faculdade de Ciências Médicas da Universidade Nova de Lisboa📍 8 sites📅 Started Dec 2023View details ↗
Phase 3RecruitingNCT05943535

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

🏥 United Therapeutics📍 150 sites📅 Started Oct 2023View details ↗
Phase 3RecruitingNCT05674994

Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis

👨‍⚕️ Jean-Marc NACCACHE, Fondation Hôpital Saint-Joseph📍 29 sites📅 Started Oct 2023View details ↗
Enrolling by InvitationNCT06327360

Illness Expectations in Pulmonary Fibrosis

🏥 Fondazione Don Carlo Gnocchi Onlus📍 2 sites📅 Started Oct 2023View details ↗
NARecruitingNCT06304207

Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease

👨‍⚕️ Shweta Gore, PhD, MGH Institute of Health Professions📍 1 site📅 Started Sep 2023View details ↗
RecruitingNCT07373288

HOXB7 and Linked Tissue and Blood Biomarkers in the Lungs of Patients With Pulmonary Fibrosis

🏥 University of Modena and Reggio Emilia📍 1 site📅 Started Jul 2023View details ↗
Phase 2, PHASE3RecruitingNCT06125327

SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

🏥 Guangzhou JOYO Pharma Co., Ltd📍 1 site📅 Started Jun 2023View details ↗
NARecruitingNCT05842681

Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis

👨‍⚕️ ahmad M shaddad, Assiut university-Faculty of Medicine📍 2 sites📅 Started Jun 2023View details ↗
Phase 2RecruitingNCT06189820

Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases

🏥 Erasme University Hospital📍 1 site📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT05139719

A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients

🏥 Sunshine Lake Pharma Co., Ltd.📍 1 site📅 Started Feb 2023View details ↗
RecruitingNCT05098717

End-expiratory Trans-pulmonary Pressure Guided PEEP Titration in Patients With Pulmonary Fibrosis and UIP Pattern Undergoing Mechanical Ventilation

🏥 University of Modena and Reggio Emilia📍 1 site📅 Started Feb 2023View details ↗
Phase 4RecruitingNCT05428826

Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis

👨‍⚕️ Aline DECHANET, Assistance Publique - Hôpitaux de Paris (AP-HP)📍 15 sites📅 Started Nov 2022View details ↗
Phase 3Enrolling by InvitationNCT04905693

Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

🏥 United Therapeutics📍 193 sites📅 Started Sep 2022View details ↗
Phase 2RecruitingNCT05389215

Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF

👨‍⚕️ Song, AIDS Malignancy Consortium📍 30 sites📅 Started Jul 2022View details ↗
RecruitingNCT05382572

Pulmonary Fibrosis Foundation Community Registry

👨‍⚕️ Kevin R Flaherty, MD, Pulmonary Fibrosis Foundation📍 1 site📅 Started Jul 2022View details ↗
← PreviousPage 3 of 4Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →